Insulin-degrading enzyme higher in subjects with metabolic syndrome.
Sofer Y, Nash Y, Osher E, Fursht O, Goldsmith G, Nahary L, Shaklai S, Tordjman KM, Serebro M, Touati EB, Yacobi Bach M, Marcus Y, Tal B, Sack J, Shefer G, Margaliot M, Landis N, Goldiner I, Abu Ahmad W, Stern N, Benhar I, Frenkel D.
Sofer Y, et al. Among authors: tal b.
Endocrine. 2021 Feb;71(2):357-364. doi: 10.1007/s12020-020-02548-2. Epub 2021 Jan 4.
Endocrine. 2021.
PMID: 33398768